Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUANTITATIVE EEG MONITORS SHOULD BE USED ONLY AS ADJUNCT

This article was originally published in The Gray Sheet

Executive Summary

QUANTITATIVE EEG MONITORS SHOULD BE USED ONLY AS ADJUNCT to accepted methods of diagnosing mental, psychological, and other illnesses, FDA's Neurological Devices Advisory Panel concluded at a Sept. 16 meeting in Gaithersburg, Maryland. Although the panel did not vote on the issue, Panel Chairman Harold Wilkinson, PhD, MD, University of Massachusetts Medical Center, Worcester, summarized panel opposition to use of the devices in primary diagnosis in remarking that "there is great concern about any marketing that claims that any single device could give a clinical diagnosis."

Latest Headlines
See All
UsernamePublicRestriction

Register

MT002824

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel